Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine in Recurrent High-Grade Gliomas
NCT00823797Phase 2Completed
- Sponsor
- University of Washington
- Start
- Oct 2008
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of bendamustine in anaplastic glioma, glioblastoma (GBM), sponsored by University of Washington. Started Oct 2008; status: completed.
02
Drugs
bendamustine
03
Conditions
anaplastic gliomaglioblastoma (GBM)
Beyond the preview
Go deeper on NCT00823797.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00823797.